<?xml version="1.0" encoding="UTF-8" ?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>nhl-low at Yahoo! Groups</title>
    <link>http://health.groups.yahoo.com/group/nhl-low/</link>
    <description>Non-Hodgkin&#39;s Lymphoma- Low Grade</description>

    <item>
      <title>LAST POST!!!!! NHL-low BECOMES NHLlow</title>
      <pubDate>Wed, 30 Sep 1998 22:33:08 GMT</pubDate>
      <dc:creator>Janice and Ben Haines</dc:creator>
      <link>http://health.groups.yahoo.com/group/nhl-low/message/912</link>
      <guid isPermaLink="true">http://health.groups.yahoo.com/group/nhl-low/message/912</guid>
      <description>Greetings, NHL-low@... is no longer, it has been converted to NHLlow@eGroups.com For most of you who just READ the posts, you will have to do NOTHING</description>
    </item>
    <item>
      <title>PR: Chiroscience (gene regulates CD4 T-cells)</title>
      <pubDate>Wed, 30 Sep 1998 11:34:20 GMT</pubDate>
      <dc:creator>by way of Janice and Ben Haines</dc:creator>
      <link>http://health.groups.yahoo.com/group/nhl-low/message/911</link>
      <guid isPermaLink="true">http://health.groups.yahoo.com/group/nhl-low/message/911</guid>
      <description>SEATTLE, WA and CAMBRIDGE, ENGLAND -- September 29, 1998 -- Chiroscience Group plc (London Stock Exchange: CRO) announced today the discovery of a gene that is</description>
    </item>
    <item>
      <title>PreTarget Press Release</title>
      <pubDate>Wed, 30 Sep 1998 04:12:01 GMT</pubDate>
      <dc:creator>Janice and Ben Haines</dc:creator>
      <link>http://health.groups.yahoo.com/group/nhl-low/message/910</link>
      <guid isPermaLink="true">http://health.groups.yahoo.com/group/nhl-low/message/910</guid>
      <description>Greetings, Here is a press release showing an update on PreTarget which we are tracking.  It looks like things didn&#39;t go well with Avicidin(R) anti-Epcam </description>
    </item>
    <item>
      <title>Angiogenesis and Waldenstrom&#39;s  (low grade lymphoma)</title>
      <pubDate>Wed, 30 Sep 1998 01:32:03 GMT</pubDate>
      <dc:creator>Matt960@...</dc:creator>
      <link>http://health.groups.yahoo.com/group/nhl-low/message/909</link>
      <guid isPermaLink="true">http://health.groups.yahoo.com/group/nhl-low/message/909</guid>
      <description>I found this medline article written in 1980 (almost 18 years ago), in which (if I understand it correctly), it seems to imply that lymphocytes in certain </description>
    </item>
    <item>
      <title>Angiogenesis: AACR Childhood Leukemia</title>
      <pubDate>Tue, 29 Sep 1998 22:44:08 GMT</pubDate>
      <dc:creator>Janice and Ben Haines</dc:creator>
      <link>http://health.groups.yahoo.com/group/nhl-low/message/908</link>
      <guid isPermaLink="true">http://health.groups.yahoo.com/group/nhl-low/message/908</guid>
      <description>Greetings, I thought I would share some more information we picked up at THE MARCH. Leukemia is a cousin to lymphoma. Lymphoma is more than twice as common as </description>
    </item>
    <item>
      <title>Teleconference</title>
      <pubDate>Mon, 28 Sep 1998 22:01:34 GMT</pubDate>
      <dc:creator>Mel Keenan</dc:creator>
      <link>http://health.groups.yahoo.com/group/nhl-low/message/907</link>
      <guid isPermaLink="true">http://health.groups.yahoo.com/group/nhl-low/message/907</guid>
      <description>For those people who did not receive this notice: Cancer Care, Inc. and Cure For Lymphoma Foundation Present LIVING WITH NON-HODGKIN&#39;S LYMPHOMA Medical Update</description>
    </item>
    <item>
      <title>Bexxar: Coulter Initiates Expanded Access Program</title>
      <pubDate>Mon, 28 Sep 1998 14:32:20 GMT</pubDate>
      <dc:creator>Janice and Ben Haines</dc:creator>
      <link>http://health.groups.yahoo.com/group/nhl-low/message/906</link>
      <guid isPermaLink="true">http://health.groups.yahoo.com/group/nhl-low/message/906</guid>
      <description>Monday September 28, 8:01 am Eastern Time Company Press Release Coulter Pharmaceutical Initiates Expanded Access Program PALO ALTO, Calif.--(BW</description>
    </item>
    <item>
      <title>THE MARCH Recap/The People/Levy/Kaminski</title>
      <pubDate>Mon, 28 Sep 1998 14:27:45 GMT</pubDate>
      <dc:creator>Janice and Ben Haines</dc:creator>
      <link>http://health.groups.yahoo.com/group/nhl-low/message/905</link>
      <guid isPermaLink="true">http://health.groups.yahoo.com/group/nhl-low/message/905</guid>
      <description>Greetings, Janice and I are back and I have so much information and data to share with you. First, a long recap of THE MARCH, it was so great to finally see </description>
    </item>
    <item>
      <title>Antibody Engineering Conference, Dec. 1-3, 1998</title>
      <pubDate>Sat, 26 Sep 1998 21:30:25 GMT</pubDate>
      <dc:creator>Judy Gibson</dc:creator>
      <link>http://health.groups.yahoo.com/group/nhl-low/message/904</link>
      <guid isPermaLink="true">http://health.groups.yahoo.com/group/nhl-low/message/904</guid>
      <description>A conference on antibody engineering has been announced for December 1-3, 1998, in Coronado (near San Diego), California. Information at</description>
    </item>
    <item>
      <title>Article on Fludaribine and 2CDA</title>
      <pubDate>Sat, 26 Sep 1998 18:18:54 GMT</pubDate>
      <dc:creator>Matt960@...</dc:creator>
      <link>http://health.groups.yahoo.com/group/nhl-low/message/903</link>
      <guid isPermaLink="true">http://health.groups.yahoo.com/group/nhl-low/message/903</guid>
      <description>For your information.   --Matt-- 1998 Jul;4 Suppl 2:S27-S36 New prospects in the treatment of indolent lymphomas with purine analogues. Cheson BD Division of</description>
    </item>
    <item>
      <title>Leukemia Society Press conference</title>
      <pubDate>Sat, 26 Sep 1998 03:59:14 GMT</pubDate>
      <dc:creator>Matt960@...</dc:creator>
      <link>http://health.groups.yahoo.com/group/nhl-low/message/902</link>
      <guid isPermaLink="true">http://health.groups.yahoo.com/group/nhl-low/message/902</guid>
      <description>With respect to today&#39;s news article about advances in immunological therapy for hematological cancers,  there is a 45 minute press conference that you can </description>
    </item>
    <item>
      <title>News article</title>
      <pubDate>Fri, 25 Sep 1998 13:32:09 GMT</pubDate>
      <dc:creator>Matt960@...</dc:creator>
      <link>http://health.groups.yahoo.com/group/nhl-low/message/901</link>
      <guid isPermaLink="true">http://health.groups.yahoo.com/group/nhl-low/message/901</guid>
      <description>For your information.   --Matt-- Breakthrough Therapies for Leukemia Are at Hand, Researchers Conclude - Less Toxic, Immune-Based Treatments Show Tremendous</description>
    </item>
    <item>
      <title>Angiogenesis: Mpls/NCI/other</title>
      <pubDate>Thu, 24 Sep 1998 01:12:56 GMT</pubDate>
      <dc:creator>Janice and Ben Haines</dc:creator>
      <link>http://health.groups.yahoo.com/group/nhl-low/message/900</link>
      <guid isPermaLink="true">http://health.groups.yahoo.com/group/nhl-low/message/900</guid>
      <description>Greetings, Here are various articles on angiogenesis. I couldn&#39;t believe THE MAN (Folkman) was 15 minutes away from us at the Minneapolis Club, last Thursday.</description>
    </item>
    <item>
      <title>Anniversary</title>
      <pubDate>Wed, 23 Sep 1998 11:58:51 GMT</pubDate>
      <dc:creator>Janice and Ben Haines</dc:creator>
      <link>http://health.groups.yahoo.com/group/nhl-low/message/899</link>
      <guid isPermaLink="true">http://health.groups.yahoo.com/group/nhl-low/message/899</guid>
      <description>Greetings, Today marks the ONE year anniversary of NHL-low. I thought I would share the first post since most of you missed it (laughter). A lot has changed in</description>
    </item>
    <item>
      <title>Fatigue</title>
      <pubDate>Tue, 22 Sep 1998 14:52:31 GMT</pubDate>
      <dc:creator>Matt960@...</dc:creator>
      <link>http://health.groups.yahoo.com/group/nhl-low/message/898</link>
      <guid isPermaLink="true">http://health.groups.yahoo.com/group/nhl-low/message/898</guid>
      <description>I thought the following might be of interest to everyone here.   --Matt-- Fatigue Is Most Prevalent and Longest-Lasting Cancer-Related Side Effect New Survey</description>
    </item>

  </channel>
</rss>
<!-- wr2.grp.sp2.yahoo.com uncompressed/chunked Sat Dec  5 11:41:13 PST 2009 -->
